Pfizer seeks U.S. authorization for vaccine booster retooled for Omicron
(Reuters) – Pfizer Inc and German partner BioNTech said on Monday they had sought U.S. authorization for a COVID-19 vaccine booster retooled to target the Omicron variant, and would have doses available to ship immediately after regulatory clearance. The request to the Food and Drug Administration was for a so-called bivalent vaccine containing the dominant …
Pfizer seeks U.S. authorization for vaccine booster retooled for Omicron Read More »










